Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Instituto do Cancer do Estado de São Paulo
University of Washington
University Health Network, Toronto
Stanford University
Northwestern University
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Swiss Cancer Institute
University of Washington
Alliance for Clinical Trials in Oncology
Peking Union Medical College Hospital
Albert Einstein College of Medicine
University of Chicago
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University of Washington
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
University of Southern California
Cancer Research UK
Barbara Ann Karmanos Cancer Institute
University of Arizona
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
University of Washington
Indiana University
University of Minnesota
Duke University
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Rutgers, The State University of New Jersey
Dartmouth-Hitchcock Medical Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center